meddevicedb.com FDA Device Reference

THROMBOLYTIC ASSESSMENT SYSTEM LOW RANGE HEPARIN MANAGEMENT TEST CONTROLS

K981178 Class II Traditional
Decision Date
1998-04-27
Sponsor / Applicant
Cardiovascular Diagnostics, Inc.

Technical Specification

510(k) Submission ID K981178
Product Code GGN
Medical Specialty / Panel Hematology
Regulation Citation 21 CFR 864.5425
Decision Date 1998-04-27
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

THROMBOLYTIC ASSESSMENT SYSTEM LOW RANGE HEPARIN MANAGEMENT TEST CONTROLS received FDA 510(k) clearance under submission number K981178, sponsored by Cardiovascular Diagnostics, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1998-04-27.

Classification & Regulation

This clearance is catalogued under FDA product code GGN and 21 CFR 864.5425, within the Hematology review panel as a Class II device.